2-Dec-2008

Subscription Info | Institutional Access | Browse the Faculties | Free Trial | Take a Tour | Top 10s | Advanced Search | Faculty Member List | About

Search   All F1000 MedicineRheumatology & C...Immune & Inflamm...         Browse ALL OF MEDICINE Rheumatology & Clinical Immunology Biomarkers of Rheumatic Disease Bone Biology, Osteoporosis & Other Diseases of Bone Cartilage Biology & Osteoarthritis Clinical Immunology Etiology, Pathogenesis & Animal Models of Rheumatic Disease Imaging of the Musculoskeletal System Immune & Inflammatory Rheumatic Diseases (inc. Arthritis) Methods, measurements & outcomes in rheumatic disease Musculoskeletal Pain & Analgesia Musculoskeletal Repair & Regeneration Orthopedics (inc. Sports Injuries) Related Sections Bone & Mineral Metabolism Urticaria, Vasculitis & Connective Tissue Disease selected for My F1000 Medicine

Browse > Rheumatology & Clinical Immunology > Immune & Inflammatory Rheumatic Diseases (inc. Arthritis) Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed (from all journals) / Most viewed (from specialty journals) / Hidden jewels Page 1 of 15. Select Page: 1 2 3 4 5 6 7 8 9 10 >> Display 10 / 20 / 50 papers per page printer friendly  10 per page20 per page50 per pageany datepast 7dpast 14dpast 30dpast 60dpast 90dpast 180dpast 1ypast 2ypast 5yall papershypothesesnew findingsconfirmationstech advancescontroversialrefutationdissentingnew on F1000newly evaluatedF1000 factormost evaluations this pageselected articlesto EndNoteRef. ManagerRefWorksBibtexProCite email [Help] Must Read F1000 Factor 6.0 Hypothesis New Finding Association between findings on delayed gadolinium-enhanced magnetic resonance imaging of cartilage and future knee osteoarthritis. Owman H, Tiderius CJ, …, Nyquist F, Dahlberg LE Arthritis Rheum 2008 Jun 58(6):1727-30 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Jukka Jurvelin with Simo Saarakkala Evaluated 1 Dec 2008 Must Read F1000 Factor 6.0 Confirmation Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers. Abou-Raya A, Abou-Raya S, Helmii M J Rheumatol 2008 Sep 35(9):1801-8 [abstract on PubMed] [related articles] [order article] Selected by | Margitta Worm with Claudia Rasche Evaluated 1 Dec 2008 Recommended F1000 Factor 3.0 New Finding Celecoxib inhibits 5-lipoxygenase. Maier TJ, Tausch L, …, Werz O, Geisslinger G Biochem Pharmacol 2008 Oct 1 76(7):862-72 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Otylia Kowal-Bielecka with Anna Lapinska Evaluated 27 Nov 2008 Recommended F1000 Factor 3.0 New Finding Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Kimura A, Naka T, …, Fujii-Kuriyama Y, Kishimoto T Proc Natl Acad Sci U S A 2008 Jul 15 105(28):9721-6 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Ann Reed with Vaidehi R Chowdhary Evaluated 24 Nov 2008 Recommended F1000 Factor 3.0 Hypothesis Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Bennett AN, McGonagle D, …, Emery P, Marzo-Ortega H Arthritis Rheum 2008 Nov 58(11):3413-8 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Juergen Braun with Xenofon Baraliakos Evaluated 21 Nov 2008 Recommended F1000 Factor 3.0 New Finding Macrophage Migration Inhibitory Factor (MIF) Promotes Colorectal Cancer. He XX, Chen K, …, Coleman TR, Al-Abed Y Mol Med 2008 Nov 9 [abstract on PubMed] [related articles] [full text] Selected by | Eric Morand Evaluated 20 Nov 2008 Must Read F1000 Factor 6.0 Hypothesis New Finding TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. Cavassani KA, Ishii M, …, Hogaboam CM, Kunkel SL J Exp Med 2008 Oct 27 205(11):2609-21 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Diego Kyburz Evaluated 20 Nov 2008 Recommended F1000 Factor 3.0 New Finding Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Ioan-Facsinay A, Willemze A, …, Huizinga TW, El-Gabalawy HS Arthritis Rheum 2008 Oct 58(10):3000-8 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Dirk Elewaut Evaluated 17 Nov 2008 Must Read F1000 Factor 6.0 New Finding Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Segal BM, Constantinescu CS, …, Kasper LH, Ustekinumab MS Investigators Lancet Neurol 2008 Sep 7(9):796-804 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Roland Martin with Manuel Friese Evaluated 14 Nov 2008 Exceptional F1000 Factor 9.0 Confirmation New Finding Tech Advance A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Xia W, Hilgenbrink AR, …, Cheng JX, Low PS Blood 2008 Oct 24 [abstract on PubMed] [related articles] [full text] Selected by | Asok Antony Evaluated 13 Nov 2008 top of page Page 1 of 15. Select Page: 1 2 3 4 5 6 7 8 9 10 >> Display 10 / 20 / 50 papers per page

---

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info